One unresolved issue in gut immunity is how mucosal T lymphocytes are activated and which antigen-presenting cell (APC) is critical for the regulation of this process. We have identified a unique population of APCs that is exclusively localized in the lamina propria. These APCs constitutively expressed the costimulatory molecule CD70 and had antigen-presenting functions. After oral infection of mice with Listeria monocytogenes, proliferation and differentiation of antigen-specific T cells occurred in the gut mucosa in situ and blockade of CD70 costimulation abrogated the mucosal T cell proliferation and effector functions. Thus, a potent CD70-dependent stimulation via specialized tissue-specific APCs is required for the proliferation and differentiation of gut mucosal T cells after oral infection.
Lymphocytes in the intestinal mucosa have several features that are distinct from those of their counterparts in the secondary lymphoid organs. Unlike T cells in the spleen and lymph node, the gut intraepithelial lymphocytes have a constitutively activated phenotype [1] [2] [3] [4] . In contrast to peripheral T cells, the intraepithelial lymphocytes are refractory to T cell receptor (TCR)-CD3 stimulation, but proliferate vigorously and secrete proinflammatory cytokines after CD2 stimulation 5, 6 . In addition, gut mucosal T cells express distinctive adhesion molecules, and their costimulatory requirements are different from those of peripheral T cells [7] [8] [9] . Furthermore, systemic administration of soluble protein antigen without adjuvant induces differentiated cytotoxic T cells in the mucosa but not in the spleen and lymph nodes 10 . Finally, induction of the gene encoding interferon-g (IFN-g) in peripheral T cells and mucosal T cells occurs through the use of different cis-regulatory elements and requires the recruitment of different transactivating factors 11 . One possible explanation for these findings is that the T cells in the mucosa may be stimulated with distinct types of antigen-presenting cells (APCs) and are thus 'imprinted' differently during their differentiation.
Various subsets of dendritic cells (DCs) have been identified in the intestinal lymphoid organs. In addition to CD11c + CD11b + CD8a À DEC-205 À and CD11c + CD11b -CD8a + DEC-205 + DCs found in the spleen and lymph nodes, Peyer's patches and mesenteric lymph nodes also contain a unique population of CD11c + CD 11b À CD8a À DEC-205 À DCs [12] [13] [14] . Another subset of CD11c lo B220 + Gr1 + CD8a + plasmacytoid DCs has also been described in mesenteric lymph nodes and Peyer's patches 15, 16 . Functionally, the Peyer's patch DCs (particularly the CD11b + and plasmacytoid subsets) differ from the splenic and lymph node DCs in their ability to induce cytokine production. For example, in contrast to splenic DC-stimulated T cells, which produce IFN-g, Peyer's patch DC-primed T cells secrete mainly interleukin 10 (IL-10) 16, 17 . Furthermore, after ligation of the costimulatory molecule RANK, Peyer's patch DCs produce IL-10, whereas splenic DCs produce IL-12 (ref. 18) . As a consequence, treatment of mice with RANK ligand during oral administration of soluble antigen enhances tolerance induction 18 . Thus, whereas splenic DCs provide a stimulatory environment, Peyer's patch DCs generally provide an inhibitory milieu. In contrast to Peyer's patch and mesenteric lymph node DCs, gut mucosal DC subsets remain poorly characterized 14 , although the presence of potentially tolerogenic subsets in the lamina propria has been suggested 19 .
One notable feature of APCs is the expression of major histocompatibility complex (MHC) and costimulatory molecules. The tumor necrosis factor-related costimulatory ligand CD70 is expressed by activated mouse DCs in vitro as well as in vivo during a protracted leishmania infection 20, 21 . CD70 is normally expressed only transiently in vivo, and its persistent expression in transgenic mice results in profound activation and proliferation of T cells, leading ultimately to exhaustion of the naive T cell pool 22, 23 . However, constitutive CD70 expression by immune cells in vivo has not been reported. Here we have identified a unique population of APCs of nonhematopoietic origin that occur exclusively in the lamina propria and constitutively express CD70. We show that CD70 + APCs are pivotal in the proliferation and differentiation of T cells in the gut mucosa.
RESULTS

Lamina propria contains a unique CD70 + cell population
Because the constitutively activated nature of T cells in the intestinal mucosa is reminiscent of the persistent activation of T cells in CD70-transgenic mice 23 , we tested whether CD70-expressing cells were present in the intestinal mucosa in naive mice. We isolated cells from the intestinal mucosa and lymphoid organs and assessed their CD70 expression by flow cytometry. We found a substantial portion of CD70 + cells in the gut lamina propria, but not in other tissues such as the spleen, Peyer's patches, mesenteric lymph nodes and bone marrow (Fig. 1a) . The CD70 + cells were distributed along the entire length of the intestine, including the colon (Fig. 1b) . Immunohistological examination confirmed their exclusive distribution in the lamina propria (Fig. 1c) .
In mice, surface CD70 is expressed by in vitro-activated B cells, mature dendritic cells and, to a lesser extent, T cells 20, 24 . Thus, we examined the phenotype of the CD70-expressing cells and compared them with bone marrow-derived dendritic cells (BMDCs; Fig. 1d ) as well as with the CD11c + cells present in the lamina propria ( Supplementary Fig. 1 online) . The CD70 + cells were negative for expression of CD3, CD4 and CD8, indicating they were not of T cell origin. They also did not express the NK1.1 or Gr-1 molecules. They had low expression of B220, but they were not B cells, because they were CD19 -. They were also not plasma cells, because B220 lo CD70 + cells were present in B cell-deficient immunoglobulin M (IgM)-deficient (mMT) mice as well as in B cell-and T cell-deficient mice deficient in recombination-activating gene 1 (Rag1 À/À ; Supplementary Fig. 1 online) . Although they had low expression of CD68 and stained for a-naphthyl acetate esterase ( Supplementary Fig. 1 online), they were negative for the macrophage markers CD11b, F4/80, MOMA-1 and MOMA-2. We also tested for expression of the DC markers CD11c, CD11b and DEC-205 and MHC [12] [13] [14] . Unlike BMDCs, the CD70 + cells did not express CD11c or CD11b. However, they expressed DEC-205 and MHC class I and class II. Among the costimulatory molecules, CD70 + cells expressed CD80 but not CD40 or CD86 (Fig. 1d) . Although DCs treated with antibody to CD40 (anti-CD40) have been reported to express CD70 (refs. 20,24), we did not find CD70 expression in BMDCs after lipopolysaccharide stimulation. When cultured, CD70 + cells were loosely adherent and heterogenous in shape and architecture, but they did not have typical dendrites ( Supplementary Fig. 1 online) . Thus, the gut lamina propria contains a distinct CD70 + cell population with an unusual phenotype.
Nonhematopoietic origin of CD70 + cells
Because of the unusual phenotype of the CD70 + cells, we sought to determine whether they were of hematopoietic lineage. Although they stained weakly with anti-B220, which is thought to recognize the isoform of CD45 expressed on B cells, they did not express the 'panleukocyte' marker CD45 (Fig. 1d) . Moreover, B220 lo CD70 + cells were also present in CD45-deficient mice (Fig. 2a) . Thus, the CD70 + cells apparently expressed an unidentified protein other than CD45 that had an epitope recognized by anti-B220. We also confirmed that they were not of hematopoietic lineage using bone marrow reconstitution experiments. Because the CD70 + cells were negative for the commonly used congenic markers (CD45 and Thy-1), we used bone marrow cells from human HLA-A2.1-transgenic mice on a C57BL/6 background as donor cells. In these mice, the HLA transgene is driven by the endogenous HLA-A2.1 promoter 25 and thus all MHC class I-positive cells should express the molecule. In the transgenic mice, CD70 + cells in the lamina propria uniformly expressed HLA-A2.1 (Fig. 2b) . For reconstitution, we transfused lethally irradiated C57BL/6 mice with bone marrow cells from HLA-A2.1-transgenic mice and, after 6 weeks, examined their gut mucosal cells for reconstitution and CD70 expression. Although the B220 hi B cells expressed HLA-A2.1 uniformly, indicating effective reconstitution, the B220 lo CD70 + cells did not express the transgene (Fig. 2b) , showing that the B220 lo CD70 + cells did not originate from bone marrow-derived stem cells. Thus, the CD70 + cells constitute a distinct class of tissue-specific cells with some of the phenotypic features of 'professional' APCs that could have been missed in experiments adhering to the conventional phenotypic markers of DCs. However, the CD70 + cells did not stain with a-smooth muscle actin, suggesting that they were not myofibroblasts, which are predominant in the gut mucosa 26 . Thus, their exact lineage remains to be determined.
Antigen-presenting function of CD70 + cells Because the CD70 + cells had some phenotypic features of APCs, we tested whether they were capable of presenting antigens. For these studies, we did not use anti-CD70 to isolate CD70 + cells, to avoid affecting their function through CD70. Because they are B220 + but CD19 À , we enriched for CD70 + cells from isolated lamina propria cell samples of C57BL/6 mice (H-2 b ) by first eliminating CD19 + B cells and then selecting B220 + cells. The isolated cell samples were more than 90% enriched, as assessed by CD70 expression ( Supplementary  Fig. 2 online) . These cells efficiently stimulated allogenic H-2 d T cells from BALB/c mice (Fig. 3a) .
We also tested the ability of CD70 + cells to stimulate a primary T cell response. We pulsed isolated CD70 + cells with lymphocytic choriomeningitis virus glycoprotein peptide (amino acids 33-41; gp (33) (34) (35) (36) (37) (38) (39) (40) (41) ) and used these to stimulate naive CD8 + T cells from P14 TCR-transgenic mice (specific for gp (33) (34) (35) (36) (37) (38) (39) (40) (41) ). The CD70 + cells stimulated and induced effector functions, as determined by proliferation, IFN-g production and cytotoxicity assays (Fig. 3b) . Moreover, the P14 TCR-transgenic T cell activation could be inhibited by CD70-blocking antibody, as determined by bromodeoxyuridine (BrdU) incorporation and IFN-g production assays (Fig. 3c) . Anti-CD70 did not directly affect T cells numbers or function (data not shown) and thus the antibody seemed to block the antigen-presenting function of CD70 + cells. Although these results suggest that the CD70 + cells have the ability to stimulate a primary T cell response, given the method used for their isolation, we could not rule out the possibility of contamination with a small number of plasmacytoid DCs in these experiments.
Phagocytic function of CD70 + cells
We compared the CD70 + cells with CD11c + cells present in lamina propria for their ability to phagocytose Listeria monocytogenes. To assess capture of L. monocytogenes, we infected lamina propria cells with 10 colony-forming units per cell of L. monocytogenes labeled with carboxyfluorescein diacetate succinimidyl diester (CFSE). Because CFSE is diluted by bacterial replication, we used a strain of D-alanine-deficient L. monocytogenes that is incapable of replication in the absence of externally supplemented D-alanine 27 . After infecting cells for 4 h at 37 1C and extensively washing them, we stained cells with anti-CD70 or anti-CD11c and examined their green fluorescence by flow cytometry. Both CD11c + cells and CD70 + cells, but not CD8 + T cells (data not shown), were able to take up L. monocytogenes efficiently (Fig. 3d) . The phagocytosis was not due to nonspecific binding, because there was little increase in fluorescence when cultures were incubated at 4 1C. We also confirmed the presence of CFSElabeled L. monocytogenes inside CD70 + cells by fluorescence microscopy ( Supplementary Fig. 2 online) . Moreover, we confirmed that CD70 + cells were able to phagocytose L. monocytogenes in vivo after oral infection of mice ( Supplementary Fig. 2 online) .
Mucosal DCs are thought to pick up antigen in the gut mucosa and migrate to mesenteric lymph nodes to prime T cells 12 . To determine if CD70 + APCs can migrate to Peyer's patches and/or mesenteric lymph nodes, and also to determine if CD70 is induced on immune cells after oral infection of mice with L. monocytogenes, we tested various organs for the presence of CD70-expressing cells 1, 2 and 8 d after L. monocytogenes infection. Although CD70-expressing cells were consistently present in the gut lamina propria, we found no CD70-expressing cells in any other organs, including the draining mesenteric lymph nodes and Peyer's patches (Fig. 3e) . Thus, CD70 expression after L. monocytogenes infection in vivo is confined to CD70 + APCs. Although these results also suggest that the CD70 + APCs remain confined to the lamina propria even during oral infection, migration of small numbers of cells may be difficult to detect by flow cytometry.
T cells proliferate in the gut mucosa
The presence of a unique population of APCs in the gut lamina propria suggested that these cells might be involved in T cell stimulation in situ. To test this, we used CD8 + T cells from P14 TCRtransgenic mice crossed with mice in which green fluorescent protein (GFP) uniformly expressed in naive and early activated CD8 + T cells is selectively turned off once the cells differentiate into phenotypically and functionally mature cytotoxic effector T cells (T-GFP mice) 28, 29 . Thus, use of the resultant 'P14-T-GFP' mice allows the identification of antigen-specific cells by gp(33-41)-MHC class I peptide tetramer (gp33 tetramer) staining as well as simultaneous assessment 30, 31 . In uninfected mice that had received adoptively transferred cells, at 4 d after transfer, the tetramer-positive cells constituted less than 2% of CD8 T cells in the spleen, mesenteric lymph nodes, Peyer's patches, intraepithelial lymphocyte compartment and lamina propria (data not shown). In infected mice, an expanded population of tetramer-positive CD8 + T cells was present only in the intraepithelial lymphocyte compartment and lamina propria (410%) after 3 d (Fig. 4a) . This expansion was not due to nonspecific proliferation of memory cells, because a similar proliferation of tetramer-positive cells also occurred in adoptive transfer experiments using CD8 + T cells from P14 TCR-transgenic mice on a Rag1 À/À background (data not shown). Although most tetramer-positive cells in the secondary lymphoid organs were GFP + , those in the lamina propria and intraepithelial lymphocyte were uniformly GFP À (Fig. 4b) , indicating that the tetramer-positive cells had differentiated into effector T cells in the gut mucosa. However, at 8 d after infection, proliferation of GFP À tetramer-positive P14
TCR-transgenic cells was readily detectable in the lymphoid organs, suggesting that they also differentiated into effector cells. We also detected cell division in various organs after infection by adoptively transferring CFSE-labeled CD8 + T cells from P14 TCRtransgenic mice into C57BL/6 recipients and treating the recipient mice by gavage with rLmgp33. On day 3 after infection, only a few tetramer-positive cells in Peyer's patches and mesenteric lymph nodes were dividing, whereas almost all tetramer-positive cells in the lamina propria and intraepithelial lymphocyte compartment had lost CFSE fluorescence, indicating that they had undergone multiple divisions (Fig. 4c) . Collectively these results suggest that the main proliferation and differentiation of antigen-specific T cells early after an oral infection occurs in the intestinal mucosa where the CD70 + APCs reside.
To determine if the increased numbers of transferred cells seen on day 3 after infection in the intraepithelial lymphocyte and lamina propria were due to accumulation of dividing cells emigrating from mesenteric lymph nodes and Peyer's patches or represented in situ proliferation, we adoptively transferred P14 TCR-transgenic CD8 + T cells into mice and infected the recipient mice with rLmgp33. Then 3 d later, we injected BrdU intravenously and, after 2h, killed the mice and assessed BrdU + cells in various organs by flow cytometry. A substantial portion of gp33 tetramer-positive cells in the lamina propria were BrdU + , whereas only a small number of cells in mesenteric lymph nodes and Peyer's patches incorporated BrdU (Fig. 4d) . Thus, antigen-specific T cells were actively replicating in the intestinal lamina propria. Because the 'unnatural' numbers of cytotoxic T lymphocyte precursors that were present in the adoptive transfer system may not have accurately represented the normal situation, we tested whether endogenous cytotoxic T lymphocytes also proliferated first in the mucosa after oral L. monocytogenes infection. We treated C57BL/6 mice with rLmgp33 by gavage and compared the frequency of gp33 peptidespecific IFN-g-producing CD8 + T cells in various organs after 3 d or 5 d of infection using an enzyme-linked immunospot (ELISPOT) assay. Unlike results obtained after adoptive transfer, we did not find substantial numbers of IFN-g-producing antigen-specific T cells in any organ at 3 d after infection (data not shown). However, we found gp33-specific IFN-g-producing CD8 + T cells in the intraepithelial lymphocyte compartment and lamina propria but not other organs 5 d after infection (Fig. 4e) . Thus, although the kinetics with adoptive transfer were faster because of excessive precursor numbers, the T cell activation pattern reflected natural infection. Our results show that at early time points after oral L. monocytogenes infection, the antigenspecific T cells proliferate and differentiate in situ in the gut mucosa.
Mucosal T cells fail to proliferate in lymphotoxin-a-deficient mice Although our results suggested that T cells proliferated and differentiated in the mucosa, they did not directly address where the initial priming of T cells occurs. Our finding that the tetramer-positive cells in Peyer's patches and mesenteric lymph nodes did not lose GFP expression on day 3 after infection did not rule out the possibility of priming in the Peyer's patches and mesenteric lymph nodes, because in T-GFP mice, early activated T cells continue to express GFP and it is only the fully differentiated effector cells that lose GFP expression 28, 29 . Therefore, to determine if Peyer's patches and mesenteric lymph nodes are required for the generation of a T cell response during L. monocytogenes infection, we compared the proliferation of adoptively transferred P14 TCR-transgenic CD8 + T cells after rLmgp33 infection in wild-type and lymphotoxin-a-deficient (Lta À/À ) mice, which lack Peyer's patches and lymph nodes 32 . Although the spleens in both groups contained equivalent numbers of tetramer-positive cells, the proliferation of tetramer-positive cells seen in the intraepithelial lymphocyte compartment in wild-type mice was completely absent from Lta À/À mice (Fig. 5a) . However, Lta À/À mice and wild-type mice had similar numbers of CD70 + APCs (Fig. 5b) . Although an intestinal homing defect has been noted for B cells in Lta À/À mice 33 , the total T cell number as well as the T cell subset composition is unaltered in these mice, suggesting that the homing defect does not apply to T cells 34 . We also did not find differences in the total CD8 + T cell numbers in wild-type versus Lta À/À mice even after L. monocytogenes infection (Fig. 5c) , and thus the homing defects cannot explain the inability of T cells to proliferate in Lta À/À mice. These results collectively suggest that Peyer's patches and/or mesenteric lymph nodes are required for the initial T cell priming after L. monocytogenes infection.
CD70 blockade abrogates mucosal T cell proliferation
The profound proliferation of effector-memory T cells seen in CD70-transgenic mice is dependent on continuous CD27-CD70 interaction, and treatment with CD70-blocking antibody can effectively reverse this to wild-type amounts 24 . Thus, to test the importance of CD70-mediated costimulation via the CD70 + APCs in antigen-specific T cell proliferation, we administered anti-CD70 on the day of adoptive transfer of P14-T-GFP CD8 + T cells and repeated it on the day of infection with oral L. monocytogenes, 4 d later. This treatment abrogated P14-T-GFP CD8 + T cell proliferation on day 3 after infection in the lamina propria and intraepithelial lymphocyte compartment (Fig. 6a) . The effect of treatment with anti-CD70 was specific to intraepithelial and lamina propria lymphocytes and did not affect the limited T cell proliferation in Peyer's patches and mesenteric lymph nodes (Fig. 6b) .
To determine whether CD70 blockade also affected the function of T cells in a nonadoptive transfer system, we measured the IFN-g response to a CD8 as well as a dominant CD4 epitope in the presence (Fig. 6c,d ).
In the experiment reported above, we could not formally prove that anti-CD70 had no effect on the T cell proliferation at systemic sites, because only small numbers of tetramer-positive cells could be detected even without antibody treatment in the Peyer's patches and mesenteric lymph nodes 3 d after oral L. monocytogenes infection. To more conclusively determine if the effect of anti-CD70 was specific to the gut or was also present at peripheral sites, we repeated the adoptive transfer experiments in control mice and mice treated with anti-CD70 using systemic rather than an oral route of antigen challenge. After adoptive transfer of P14-T-GFP CD8 + T cells, we injected the mice intraperitoneally with gp33 peptide in incomplete Freund's adjuvant and, 3 d later, monitored the proliferation of tetramer-positive cells in various organs. In these conditions, although more than 80% of CD8 + T cells accumulating in the peritoneal cavity were tetramer-positive, treatment with anti-CD70 had no effect on their numbers. In contrast, CD70 blockade diminished the proliferation of tetramer-positive cells in the gut mucosa (Fig. 6e) , showing that the effect of anti-CD70 was confined to the gut where CD70 + APCs were present.
The results presented above suggested that the proliferation and differentiation of antigen-specific T cells in the gut at early time points was dependent on stimulation by CD70 + APCs. However, after oral L. monocytogenes infection, the bacteria also spread to Peyer's patches and mesenteric lymph nodes, reaching peak titers on day 2, and to the spleen and liver, reaching peak titers on day 4 after infection 36 . Thus, T cells can presumably be activated by APCs in the lymphoid organs independently of the gut mucosa. Consistent with this, we detected appreciable numbers of tetramer-positive cells at systemic sites after 8 d of infection (Fig. 4a) . To elucidate the relevance of CD70 + APCs at later time points, we tested the effect of CD70 blockade on the T cell Supplementary Fig. 3 online) . These results suggest that in general, potent stimulation by CD70 + APCs is required for T cell proliferation in the gut mucosa.
DISCUSSION
Here we have shown that the proliferation and differentiation of T cells after oral infection occurred in the intestinal mucosa in situ and that restimulation via a unique tissue-specific APC was critical for this process. These findings may help elucidate how a robust immune response can be generated in the generally suppressive environment of the gut mucosa.
Several subsets of professional antigen presenting DCs have been described, based on the phenotype and function 14, [37] [38] [39] . Although they are of nonhematopoietic lineage, the CD70 + APCs share some of the features of 'professional' APCs, including expression of MHC class II, DEC-205 and costimulatory molecules CD70 and CD86. Moreover, they seem to be able to take up bacteria and present antigens to T cells in vitro as well as in vivo. However, unlike the other DC subsets, the CD70 + APC is restricted in distribution to the lamina propria compartment. Thus, CD70 + APCs seem to constitute a distinct class of tissue-specific APCs. Further studies should clarify the exact lineage of these cells.
The intestinal immune system must delicately balance the induction of tolerance to harmless commensal bacteria and dietary antigens with the induction of active immunity to pathogens. Probably because the former outnumber the latter, the gut has a predisposition for tolerance induction 14 . DCs in Peyer's patches and mesenteric lymph nodes elicit suppressive cytokines to the same stimuli that elicit stimulatory cytokines in splenic DCs 17, 18 . Moreover, intestinal epithelial cells as well as intraepithelial lymphocytes produce copious amounts of the potentially immunosuppressive cytokine transforming growth factorb [40] [41] [42] . Despite this apparently suppressive environment, intraepithelial lymphocytes are constitutively activated in terms of their phenotype [1] [2] [3] [4] . Moreover, the T cell responses to infections are more robust and more prolonged in the gut mucosa than in the periphery [43] [44] [45] [46] . Our results suggest that strong costimulation provided by CD70 + APCs may be necessary to activate T cells in the generally suppressive intestinal milieu.
The issue of where and how intestinal T cells are activated has remained controversial. Based on the 'oligoclonality' of T cell repertoire in the intraepithelial lymphocytes that resembles T cell blasts in afferent lymph in the thoracic duct, it was originally proposed that T cells are primed to antigen in Peyer's patches or mesenteric lymph nodes, then migrate to blood through the thoracic duct before accumulating in the lamina propria and intraepithelial lymphocyte compartment 47, 48 . However, studies using mice that lack Peyer's patches, such as mice treated in utero with lymphotoxin-b receptorimmunoglobulin fusion protein or lymphotoxin-b-deficient mice or mice heterozygous for deficiency in lymphotoxin-a or lymphotoxin-b, have shown that Peyer's patches are not indispensable for either mucosal IgA responses or tolerance induction 49, 50 . Because impaired IgA responses have been noted in lymphotoxin-a-deficient and lymphotoxin-b receptor-deficient mice that lack both Peyer's patches and mesenteric lymph nodes, it was suggested that mesenteric lymph nodes might act as an alternative site for the induction of mucosal immunity 32, 49, [51] [52] [53] . Even that view has been challenged by a study showing that the mucosal IgA deficiency in Lta À/À mice could be reversed by transfer of bone marrow cells from wild-type mice, suggesting that the presence of lymphotoxin rather than intact Peyer's patches or mesenteric lymph nodes is required for mucosal IgA production 33 .
The site of antigen priming for T cell immunity has not been studied in situations in which Peyer's patches and mesenteric lymph nodes are absent. Our results showing that T cells in the mucosa are unable to proliferate in Lta À/À mice, which lack Peyer's patches and lymph nodes, despite having CD70 + APCs capable of providing stimulation, suggest that priming occurs in Peyer's patches and/or mesenteric lymph nodes for the gut mucosal T cell response. This is also consistent with previous studies showing that the initial priming of antigen-specific cytotoxic T lymphocyte occurs in the mesenteric lymph node 30, 31 as well as with a study showing that Lta À/À mice are more susceptible than wild-type mice to L. monocytogenes infection 54 . Although defects in adhesion molecules and chemokine expression in Lta À/À mice have been reported to inhibit intestinal migration of B cells 33, 34 , T cell migration seems to be unaffected in these mice 34 . Thus, the defect in T cell proliferation seen in Lta À/À mice is a consequence of lack of priming rather than defective homing of CD8 + T cells.
Collectively our results suggest that although T cells may be primed in the Peyer's patches and/or mesenteric lymph nodes, restimulation via the tissue-specific CD70 + APCs is critical for the proliferation and differentiation of T cells in the gut mucosa. Because CD70-mediated costimulation is critical during the mucosal stimulation, our findings may also provide a tool for augmenting the mucosal response to an oral vaccine or for interfering with excessive mucosal immune response in situations such as inflammatory bowel disease.
METHODS
Mice. C57BL/6, BALB/c, mMT and Rag1 À/À mice were purchased from the Jackson Laboratory. P14 TCR-transgenic mice on a Rag1 À/À background were purchased from Taconic Farms. T-GFP-transgenic mice 28 backcrossed to C57BL/6 mice for seven generations were bred with P14 TCR-transgenic mice specific for gp (33) (34) (35) (36) (37) (38) (39) (40) (41) 55 that had been extensively backcrossed to C57BL/6 mice (N10; a gift from R. Ahmed, Emory University, Atlanta, Georgia) to derive P14-T-GFP mice. Lta À/À mice 32 have been described previously. All mice were maintained in specific pathogen-free conditions in microisolater cages and were used when they were 6-10 weeks of age. All animal experiments were approved by the Institutional Review Board of the CBR Institute for Biomedical Research (Boston, Massachusetts).
Adoptive transfer. Naive CD8 + T cells were purified from splenocytes of P14 TCR-transgenic or P14-T-GFP mice by negative selection with the murine T cell CD8 subset isolation kit (R&D Systems) according to the manufacturer's instructions. The isolated cells were more than 90% pure and more than 95% of them expressed GFP and had high expression of L-selectin and were CD69 À . C57BL/6 recipient mice were injected intravenously with 8 Â 10 6 purified CD8 + T cells. In some experiments, CD8 + T cells from P14 TCR-transgenic mice were labeled with 1 mM CFSE before transfer.
Infection with L. monocytogenes. Mice were treated by gavage with 5 Â 10 9 colony-forming units of rLmgp33 (ref. 29; a gift from H. Shen, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania) and, at various times after infection, spleens, mesenteric lymph nodes, Peyer's patches and intestines were collected. In some experiments, isolated gut mucosal (lamina propria and intraepithelial) cells were infected with a D-alanine-deficient L. monocytogenes strain (a gift from F. Frankel, University of Pennsylvania) 27 labeled with CFSE.
Isolation of lymphocytes from Peyer's patches and lamina propria and intraepithelial lymphocytes. Intestinal lymphocytes were isolated as 7 0 4 VOLUME 6 NUMBER 7 JULY 2005 NATURE IMMUNOLOGY described 56 . Peyer's patches were excised and the intestine was flushed with 50 ml PBS and was cut longitudinally along its entire length. After three washes, the intestine was cut into small pieces, was transferred to a 50-ml tube in 20 ml of Hank's balanced salt solution containing 5% FBS and 0.1 mM EDTA and was shaken with a magnetic stirrer for 20 min. The supernatant was collected, the EDTA treatment was repeated two more times and intraepithelial lymphocytes were isolated from the pooled supernatants. Finally, the intestinal pieces were digested with 200 U/ml of collagenase (type VIII; Sigma) with shaking at 37 1C for 30 min. Lamina propria cells were isolated from the supernatants. For phenotyping and isolation of CD70 + cells, intraepithelial and lamina propria cells were used without further purification. In all other experiments detecting T cells, both intraepithelial and lamina propria lymphocytes were purified on a discontinuous Percoll gradient. The cells were washed two times in PBS and were suspended in 8 ml of 44% Percoll, layered on 5 ml of 67% Percoll and centrifuged for 20 min at 600g. The interface cells were collected, washed and stained with antibodies for flow cytometry. 23 . Immunostaining and flow cytometry were done as described 29 with a FACScan flow cytometer (BD Biosciences).
Generation of BMDCs. Bone marrow cells were cultured for 7 d with 20 ng/ml each of recombinant granulocyte-monocyte colony-stimulating factor and IL-4 (R&D systems) and were matured by culture for 1 more day with 1 mg/ml of lipopolysaccharide (Sigma).
Immunomagnetic isolation and allogenic and peptide stimulation. Gut mucosal (lamina propria) cells from C57BL/6 mice were first stained with CD19-coated Miltenyi beads and samples were depleted of B cells with a Miltenyi miniMACS system. Cells were subsequently stained with B220-coated Miltenyi beads for positive selection of B220 + CD70 + cells. The isolated cells were more than 90% pure, as assessed by staining with anti-CD70. For generation of an 'alloresponse' , various numbers of CD70 + cells or BMDCs from C57BL/6 mice were irradiated (4,000 rads) and were cultured for 5 d in triplicate in 96-well plates with 1 Â 10 5 T cells (purified with T cell enrichment columns from R&D Systems) from BALB/c mice, were pulsed for 6 h with 3 H[thymidine] (0.5 mCi/well) and were collected; thymidine incorporation was measured with a Packard Topcount collector and microplate reader. For the generation of a peptide-specific response, isolated CD70 + cells, CD19 + B cells, EL-4 cells and BMDC were pulsed with gp(33-41) (KAVYNFATC; 5 mg/ml; synthesized at BioSource), were washed and were used to stimulate purified CD8 + T cells from P14 TCR-transgenic mice. Proliferation was measured by 3 H[thymidine] incorporation after 4 d and intracellular IFN-g production and cytotoxicity were measured after 6 d using peptide-pulsed EL-4 cells as described 28 . For measurement of listeria-specific CD4 T cell responses, lamina propria cells from L. monocytogenes-infected C57BL/6 mice were stimulated with the BMDCs pulsed for 6 h with LLO(190-201) 35 (NEKYAQAYPNVS; 5 mg/ml) in the presence of brefeldin A.
ELISPOT assay. Millipore multiscreen filter plates (Millipore) coated with antimouse IFN-g (AN-18; BD Pharmingen) were used for ELISPOT assays. Singlecell suspensions were plated in wells containing gp(33-41)-pulsed or unpulsed MC57G cells. Cytokine production was detected after 24 h with biotinylated anti-IFN-g (R4-6A2; BD Pharmingen) followed by alkaline phosphatase-conjugated mAb to biotin (Vector Laboratories) and the precipitating alkaline phosphatase substrate nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate (Pierce). Spots were counted with a digital imager and Immunospot software (version 3; Cellular Technology). The number of spots was normalized to the number of CD8b + T cells (determined in parallel by flow cytometry) to give a final result of spot-forming cells per 1 Â 10 4 cells.
Immunohistology. Intestinal tissue was embedded in optimum cutting temperature medium and was 'snap-frozen' in liquid nitrogen. Cryostat sections 10 mm in thickness were 'reacted with' mAb to CD70 followed by goat anti-rathorseradish peroxidase and Nova Red substrate (Vector Laboratories) and were counterstained with 1% methyl green for examination with a light microscope.
BrdU incorporation assay. In vivo BrdU labeling was done as described 57 . At 2 h before being killed, mice were injected intraperitoneally with 1 ml of BrdU labeling reagent (Zymed) per 100 g body weight. Lymphocytes collected from various organs were stained externally with anti-mouse CD8-indodicarbocyanine and gp33 tetramer-phycoerythrin, were fixed and permeabilized and were stained internally with anti-BrdU-DNase-fluorescein isothiocyanate (BectonDickinson) as described 29 . For in vitro BrdU assay, 22 ml of labeling reagent was added to 200 ml of culture medium in 96-well plates and, after overnight incubation, cells were stained for BrdU as described above.
Esterase staining. The a-naphthyl acetate esterase staining kit from Sigma Diagnostics was used for intracellular esterase staining, according to the manufacturer's instructions. After counterstaining with hematoxylin, dark staining cells in five high-power fields were counted using light microscopy.
Antibody treatment. Mice were given anti-mouse CD70 (clone 3B9) or control hamster mAb (100 mg per intraperitoneal injection) every 2 d.
Note: Supplementary information is available on the Nature Immunology website.
